The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethyl
β¦ LIBER β¦
Formulations for delivery of therapeutic proteins
β Scribed by Snjezana Stolnik; Kevin Shakesheff
- Book ID
- 106364340
- Publisher
- Springer Netherlands
- Year
- 2008
- Tongue
- English
- Weight
- 281 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0141-5492
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Delivery of therapeutic proteins
β
Dipak S. Pisal; Matthew P. Kosloski; Sathy V. Balu-Iyer
π
Article
π
2010
π
John Wiley and Sons
π
English
β 298 KB
Challenges for the development of therap
β
R. MΓΌller
π
Article
π
2009
π
Elsevier
π
English
β 51 KB
Disulfide-Crosslinked Polyion Micelles f
β
Michael J. Heffernan; Niren Murthy
π
Article
π
2009
π
Springer
π
English
β 452 KB
Past, present, and future technologies f
β
Rajesh Singh; Shailesh Singh; James W. Lillard
π
Article
π
2008
π
John Wiley and Sons
π
English
β 346 KB
Biological drugs are usually complex proteins and cannot be orally delivered due to problems related to degradation in the acidic and protease-rich environment of the gastrointestinal (GI) tract. The high molecular weight of these drugs often results in poor absorption into the periphery when admini
Improving protein therapeutics with sust
β
Putney, Scott D.; Burke, Paul A.
π
Article
π
1998
π
Nature Publishing Group
π
English
β 611 KB
[Methods in Molecular Biology] Therapeut
β
Voynov, Vladimir; Caravella, Justin A.
π
Article
π
2012
π
Humana Press
β 382 KB